---

---

health   published : Today   

save search

---

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published: 2024-04-19 (Crawled : 10:00) - globenewswire.com
ALVO | $12.89 0.7% 0.78% 220 |

n/a

| Email alert Add to watchlist
KMDA | $5.1 0.39% -0.1% 6.5K |

Health Technology

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
humira biosimilar approved for agreement

---

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
PRQR | $1.86 -2.11% -2.15% 0 |

Health Technology

| Email alert Add to watchlist
defense

---

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
TLSA | News | $0.64 24.76% 17.24% 22K |

Health Technology

| Email alert Add to watchlist
today anti-cd3 life neurology foralumab sclerosis sciences results study

---

Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law Firm
Published: 2024-04-19 (Crawled : 11:00) - prnewswire.com
BSAQ | $10.2 2.45% 380 |

| Email alert Add to watchlist
QDEL M | $38.26 -1.16% -1.12% 10 |

Health Technology

| Email alert Add to watchlist
VFS | $2.71 -0.37% -0.74% 2.4M |

| Email alert Add to watchlist
corporation deadline quidel

---

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.32 -8.33% -10.77% 190K |

Health Technology

| Email alert Add to watchlist
ocu410 armada trial therapy

---

FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M |

Health Technology

| Email alert Add to watchlist
fda for car-t

---

Sanofi Cuts Jobs in U.S. Vaccines Division as Part of Restructuring
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
SNY | News | $45.39 -1.56% -1.58% 4.3M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
sanofi

---

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M |

Health Technology

| Email alert Add to watchlist
XOMA | News | $24.59 1.4% 2.84% 15K |

Health Technology

| Email alert Add to watchlist
companies biopharma platform

---

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
NURO | $3.65 2.24% 10.3% 3.9K |

Health Technology

| Email alert Add to watchlist

---

The Gross Law Firm Reminds agilon health, inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - AGL
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
VTYX | $4.35 -0.69% -0.57% 650K |

Manufacturing

| Email alert Add to watchlist
INVZ | News | $1.06 -0.94% -1.42% 600 |

| Email alert Add to watchlist
deadline

---

Shareholders that lost money on SSR Mining Inc.(SSRM) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
DKS | $195.22 -0.87% 0.4% 6 |

Retail Trade

| Email alert Add to watchlist
AVXL | $3.8 -6.63% -7.11% 0 |

Health Technology

| Email alert Add to watchlist
SSRM | News | $5.14 1.58% 1.56% 0 |

Non-Energy Minerals

| Email alert Add to watchlist
mining

---

Class Action Filed Against iRobot Corporation (IRBT) Seeking Recovery for Investors - Contact The Gross Law Firm
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
IESC | $115.87 -0.72% -0.7% 0 |

Industrial Services

| Email alert Add to watchlist
AVXL | $3.8 -6.63% -7.11% 0 |

Health Technology

| Email alert Add to watchlist
EVLV | $3.94 2.34% 2.28% 1.4M |

| Email alert Add to watchlist
IRBT | $7.25 3.13% 3.17% 2.5K |

Consumer Durables

| Email alert Add to watchlist
corporation for

---

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M |

Health Technology

| Email alert Add to watchlist
RPRX | $27.89 1.01% 0.99% 35 |

Health Technology

| Email alert Add to watchlist
first pharma royalty financial results

---

Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
SNY | News | $45.39 -1.56% -1.58% 4.3M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
TAK | News | $13.16 0.08% 0.15% 2.1K |

Health Technology

| Email alert Add to watchlist
MIRM | $23.57 -1.17% -1.06% 400K |

Health Technology

| Email alert Add to watchlist
report million reach treatment market

---

Addex to Present at the Swiss Biotech Day 2024
Published: 2024-04-19 (Crawled : 05:00) - globenewswire.com
ADXN | News | $20.96 -4.73% 8.37% 0 |

Health Technology

| Email alert Add to watchlist
day biotech

---

How retailers and “payviders” are disrupting U.S. healthcare in 2024
Published: 2024-04-19 (Crawled : 08:00) - clarivate.com
LHCG | $169.81 0.47% -0.03% 0 |

Health Services

| Email alert Add to watchlist

---

Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
Published: 2024-04-19 (Just crawled : 13:00) - biospace.com/
MRK | $125.23 -0.11% 0.41% 1K |

Health Technology

| Email alert Add to watchlist
health treatment for canada advanced keytruda

---

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Published: 2024-04-19 (Just crawled : 13:00) - biospace.com/
SRDX | $26.39 -0.49% -0.57% 140K |

Health Technology

| Email alert Add to watchlist
report financial results

---

Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published
Published: 2024-04-19 (Just crawled : 13:00) - biospace.com/
ENSC | $0.5802 -7.88% -8.49% 1.3K |

Health Technology

| Email alert Add to watchlist
conference presentation growth

---

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
Published: 2024-04-19 (Just crawled : 13:00) - biospace.com/
SNY | News | $45.39 -1.56% -1.58% 4.3M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $145.74 0.67% -0.18% 7M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
miss

---

Gainers vs Losers

58%

42%

Top 10 Gainers

ZCMD | $1.45 5.84% 49.63% 15M |

Commercial Services

AULT | $0.2421 -7.7% 45.23% 16M |

Manufacturing

XPON | News | $3.15 63.21% 33.9% 100K |

EGOX | $0.036 12.15% 31.56% 32M |

TIRX | $0.8 65.02% 25.95% 410K |

VTNR 4 | $1.31 33.78% 25.82% 220K |

Industrial Services

GDHG | $0.263 21.76% 25.34% 1.3M |

TPET | $0.3279 -3.56% 23.57% 11M |

n/a

HOLO | $2.95 31.7% 22.49% 37M |

MTNB | $0.19 -1.04% 14.58% 950K |

Health Technology

---

Your saved searches

---